SFX by Ex Libris Inc.

Title:	Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer
Source:	Science [0036-8075] Ye, X yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Haseltine, William A. "Discovering genes for new medicines." Scientific American 276.3 (1997): 92-7.
description	2.	Bouard, D. "Viral vectors: from virology to transgene expression." British Journal of Pharmacology 157.2 (2009): 153-165.
description	3.	Dyall, J. "Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system." Proceedings of the National Academy of Sciences of the United States of America 96.22 (1999): 12849-.
description	4.	Rivera, V M M. "A humanized system for pharmacologic control of gene expression." Nature medicine 2.9 (1996): 1028-1032.
description	5.	Lasne, P. ""Genetic Doping" with erythropoietin cDNA in primate muscle is detectable." Molecular therapy 10.3: 409-410.
description	6.	Fee, Conan J. "PEG-proteins: Reaction engineering and separation issues." Chemical engineering science 61.3 (2005): 924-939.
description	7.	Merten, O-W W. "Current issues in adeno-associated viral vector production." Gene therapy 12.S1 (2005): -61.
description	8.	Ravine, P. "Recommendations of the 2006 Human Variome Project meeting." Nature genetics 39.4 (2007): 433-6.
description	9.	Goverdhana, S. "Regulatable gene expression systems for gene therapy applications: Progress and future challenges." Molecular therapy 12.2 (2005): 189-211.
description	10.	Verhaagen, Joost J. "Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system." Methods 28.2 (2002): 182-94.
description	11.	Shaner, N. "Advances in fluorescent protein technology." Journal of cell science 120.24 (2007): 4247-4260.
description	12.	Nagasaki, Y. "Block copolymer micelles for drug delivery: design, characterization and biological significance." Advanced drug delivery reviews 47.1: 113-131.
description	13.	Gaffney, Gary R R. "Gene doping: a review of performance-enhancing genetics." The Pediatric clinics of North America 54.4 (2007): 807-22.
description	14.	Mansilla Soto, J. "DNA Structure Modulates the Oligomerization Properties of the AAV Initiator Protein Rep68 (DNA Structure Regulates AAV Rep68 Oligomerization)." PLOS pathogens 5.7 (2009).
description	15.	Russell, Boris J. "Parvovirus vectors: use and optimisation in cancer gene therapy." Expert reviews in molecular medicine 6.16 (2004): 1-24.
description	16.	Pollock, R. "Dimerizer-regulated gene expression." Current opinion in biotechnology 13.5 (2002): 459-467.
description	17.	Ponnazhagan, S. "Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands." Journal of virology 76.24 (2002): 12900-7.
description	18.	Liu, J. "Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes." Cell 66.4 (1991): 807-15.
description	19.	Dunn, Warwick B B. "Measuring the metabolome: current analytical technologies." The Analyst 130.5 (2005): 606-25.
description	20.	Fisher, James W W. "Erythropoietin: physiology and pharmacology update." Experimental biology and medicine 228.1 (2003): 1-14.